Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7217665 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7224539 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7223700 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7224048 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL20856911 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7218790 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL15294513 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7223667 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7223773 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 | |
| SCHEMBL7223100 | 1.00 | CA1 (0.53) | CA1NAAAEPHX1TSHRACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2174645-B1 | Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate | SYMRISE AG (DE) | 2015-07-29 | — | — | EP | disclosed |
| US-9050261-B2 | Compositions comprising fragrance substances and comprising cetyl nonanoate and/or stearyl nonanoate | SYMRISE AG (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | SYMRISE AG (DE) | 2011-04-21 | — | — | US | disclosed |
| EP-2174645-A2 | Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate | Symrise GmbH & Co. KG (DE) | 2010-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | CUTA, FHIT, FAM83A | CA1 1075/4885NAAA 425/4885EPHX1 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.